Home » Topics » Regulatory

Regulatory
RSS

First approval obtained for new BPH therapeutic from GSK

Dec. 4, 2001

Teveten HCT receives marketing approval in U.S.

Dec. 4, 2001

FDA clears injectable antibiotic Invanz

Dec. 3, 2001

FDA marketing approval granted for improved form of Ritalin for ADHD

Dec. 3, 2001

Canadian approval for Fludara as NHL treatment

Dec. 3, 2001

Zenapax enters phase II trial in patients with chronic asthma

Dec. 3, 2001

Basiliximab: use in GI inflammatory disorders

Nov. 29, 2001

FDA approves expanded use of Myoview

Nov. 28, 2001

European Commission extends pramipexole's indications to include initial monotherapy

Nov. 28, 2001

Sheffield initiates budesonide inhalation suspension study

Nov. 27, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...